241 related articles for article (PubMed ID: 23994419)
41. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
[TBL] [Abstract][Full Text] [Related]
42. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
[TBL] [Abstract][Full Text] [Related]
43. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.
Wever-Pinzon O; Selzman CH; Drakos SG; Saidi A; Stoddard GJ; Gilbert EM; Labedi M; Reid BB; Davis ES; Kfoury AG; Li DY; Stehlik J; Bader F
Circ Heart Fail; 2013 May; 6(3):517-26. PubMed ID: 23479562
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States.
Cabrera AG; Sundareswaran KS; Samayoa AX; Jeewa A; McKenzie ED; Rossano JW; Farrar DJ; Frazier OH; Morales DL
J Heart Lung Transplant; 2013 Nov; 32(11):1107-13. PubMed ID: 24002006
[TBL] [Abstract][Full Text] [Related]
45. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device.
Demirozu ZT; Radovancevic R; Hochman LF; Gregoric ID; Letsou GV; Kar B; Bogaev RC; Frazier OH
J Heart Lung Transplant; 2011 Aug; 30(8):849-53. PubMed ID: 21530318
[TBL] [Abstract][Full Text] [Related]
46. Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices.
Ventura PA; Alharethi R; Budge D; Reid BB; Horne BD; Mason NO; Stoker S; Caine WT; Rasmusson B; Doty J; Clayson SE; Kfoury AG
Clin Transplant; 2011; 25(4):E390-5. PubMed ID: 21401721
[TBL] [Abstract][Full Text] [Related]
47. Initial experience with routine less invasive implantation of HeartMate II left ventricular assist device without median sternotomy.
Anyanwu AC; Itagaki S; Pinney S; Adams DH
Eur J Cardiothorac Surg; 2014 Dec; 46(6):985-90. PubMed ID: 24623169
[TBL] [Abstract][Full Text] [Related]
48. Optimal Timing of Heart Transplant After HeartMate II Left Ventricular Assist Device Implantation.
Steffen RJ; Blackstone EH; Smedira NG; Soltesz EG; Hoercher KJ; Thuita L; Starling RC; Mountis M; Moazami N
Ann Thorac Surg; 2017 Nov; 104(5):1569-1576. PubMed ID: 28651783
[TBL] [Abstract][Full Text] [Related]
49. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
Teuteberg JJ; Ewald GA; Adamson RM; Lietz K; Miller LW; Tatooles AJ; Kormos RL; Sundareswaran KS; Farrar DJ; Rogers JG
J Am Coll Cardiol; 2012 Jul; 60(1):44-51. PubMed ID: 22541834
[TBL] [Abstract][Full Text] [Related]
50. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
[TBL] [Abstract][Full Text] [Related]
51. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
[TBL] [Abstract][Full Text] [Related]
52. The spectrum of complications following left ventricular assist device placement.
Yuan N; Arnaoutakis GJ; George TJ; Allen JG; Ju DG; Schaffer JM; Russell SD; Shah AS; Conte JV
J Card Surg; 2012 Sep; 27(5):630-8. PubMed ID: 22978843
[TBL] [Abstract][Full Text] [Related]
53. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
Park SJ; Milano CA; Tatooles AJ; Rogers JG; Adamson RM; Steidley DE; Ewald GA; Sundareswaran KS; Farrar DJ; Slaughter MS;
Circ Heart Fail; 2012 Mar; 5(2):241-8. PubMed ID: 22282104
[TBL] [Abstract][Full Text] [Related]
54. Use of ventricular assist devices in patients with mitral valve prostheses.
Goda A; Takayama H; Koeckert M; Pak SW; Sutton EM; Cohen S; Uriel N; Jorde U; Mancini D; Naka Y
J Card Surg; 2011 May; 26(3):334-7. PubMed ID: 21480991
[TBL] [Abstract][Full Text] [Related]
55. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
56. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
[TBL] [Abstract][Full Text] [Related]
57. Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding.
Shah KB; Gunda S; Emani S; Kanwar MK; Uriel N; Colombo PC; Uber PA; Sears ML; Chuang J; Farrar DJ; Brophy DF; Smallfield GB
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141860
[TBL] [Abstract][Full Text] [Related]
58. Postoperative Outcomes of the Largest HeartMate-II Experience in Turkey.
Ertugay S; Engin C; Nalbantgil S; Kocabaş S; Balcioglu O; Engin Y; Yagdi T; Ozbaran M
Transplant Proc; 2015 Jun; 47(5):1499-502. PubMed ID: 26093751
[TBL] [Abstract][Full Text] [Related]
59. Outcomes and hospital admissions during long-term support with a HeartMate II.
Rossing K; Jung MH; Sander K; Olsen PS; Hansen PB; Boesgaard S; Gustafsson F
Scand Cardiovasc J; 2015; 49(6):367-75. PubMed ID: 26400060
[TBL] [Abstract][Full Text] [Related]
60. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
